Skip to main content
ESMO Open logoLink to ESMO Open
. 2016 Nov 9;1(5):e000106corr1. doi: 10.1136/esmoopen-2016-000106corr1

Correction

PMCID: PMC5115813  PMID: 27905571

Cardoso F. Highlights in breast cancer from ASCO 2016. ESMO Open 2016;1:e000106.

The author's Disclaimer statement should have been included in the original publication. This is:

Disclaimer FC is a consultant for: Astellas/Medivation, Astra Zeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GSK, Macrogenics, Merck-Sharp, Merus BV, Novartis, Pfizer, Pierre-Fabre, Roche, Sanofi, Teva.

RESOURCES